Internal Medicine, Infectious Disease · Scottsdale, AZ
NPI
1831193556
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
9060 E Via Linda Ste 250
Scottsdale, AZ, 85258
Phone (602) 443-0184
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
1,152 services
Medicare patients, 2024
295
Average age 73
Drug cost, 2024
$3.7M
2,212 prescriptions
Company payments, 2025
$2,273
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura K Schroeder was code 99233 (hospital e&m - subsequent), 674 times for 150 patients. In total Laura K Schroeder billed 1,152 services in 15 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 674 | 150 | $89.38 | $60K |
| 99214 Office E&M - Established | Office | 176 | 94 | $93.59 | $16K |
| 99213 Office E&M - Established | Office | 56 | 44 | $62.61 | $3,506 |
| 99222 Hospital E&M - Initial | Facility | 54 | 50 | $96.05 | $5,187 |
| 99223 Hospital E&M - Initial | Facility | 51 | 47 | $129.98 | $6,629 |
| 99204 Office E&M - New | Office | 50 | 50 | $125.80 | $6,290 |
| 99232 Hospital E&M - Subsequent | Facility | 36 | 29 | $60.15 | $2,165 |
| 99215 Office E&M - Established | Office | 19 | 17 | $135.33 | $2,571 |
By year: 2022 $107K for 1,254 services; 2023 $142K for 1,530 services; 2024 $106K for 1,152 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura K Schroeder prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 190 prescriptions and refills. In total Laura K Schroeder wrote 2,212 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 190 | 200 | 23 | $814K |
| Azithromycin Generic | 130 | 178 | 36 | $2,720 |
| Fluconazole Generic | 129 | 206 | 33 | $7,328 |
| Ethambutol Hcl Generic | 109 | 135 | 24 | $4,929 |
| Doxycycline Hyclate Generic | 66 | 88 | 20 | $2,439 |
| Ertapenem Ertapenem Sodium | 65 | 65 | 16 | $23K |
| Amoxicillin Generic | 56 | 58 | 11 | $371 |
| Rifampin Generic | 55 | 67 | Under 11 | $4,781 |
| Juluca Dolutegravir/Rilpivirine | 51 | 57 | Under 11 | $203K |
| Tivicay Dolutegravir Sodium | 50 | 50 | Under 11 | $173K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 50 | 76 | 16 | $856 |
| Arikayce Amikacin Liposomal/Neb.Accessr | 47 | 47 | Under 11 | $695K |
| Cephalexin Generic | 46 | 65 | Under 11 | $1,018 |
| Posaconazole Generic | 42 | 42 | Under 11 | $39K |
| Rifabutin Generic | 40 | 40 | Under 11 | $25K |
Brand drugs: - claims; generic drugs: 1,506 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura K Schroeder $2,273 ($2,273 in general payments such as food, travel and fees) from 21 companies. The largest payer was ViiV Healthcare Company with $473.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 16 | $473 |
| Insmed, Inc. INSM | 10 | $219 |
| Melinta Therapeutics, LLC | 13 | $174 |
| Gilead Sciences, Inc. GILD | 8 | $173 |
| Actelion Pharmaceuticals US, Inc. JNJ | 5 | $159 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $135 |
| Abbvie Inc. ABBV | 2 | $131 |
| Verona Pharma, Inc. VRNA | 4 | $129 |
| Shionogi Inc 4507.T | 1 | $121 |
| Merck Sharp & Dohme LLC MRK | 6 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.